Novel Somatostatin Receptor Ligands Therapies for Acromegaly

Surgery is considered the treatment of choice in acromegaly, but patients with persistent disease after surgery or in whom surgery cannot be considered require medical therapy. Somatostatin receptor ligands (SRLs) octreotide (OCT), lanreotide, and the more recently approved pasireotide, characterize...

Descripción completa

Detalles Bibliográficos
Autores principales: Paragliola, Rosa Maria, Salvatori, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845985/
https://www.ncbi.nlm.nih.gov/pubmed/29563895
http://dx.doi.org/10.3389/fendo.2018.00078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845985/
https://www.ncbi.nlm.nih.gov/pubmed/29563895
http://dx.doi.org/10.3389/fendo.2018.00078

Ejemplares similares